Bortetor 2mg Injection 1s
BORTEZOMIB
Bortetor 2 Injection should only be administered by a qualified medical professional The dosage and frequency of injections will be determined by your doctor depending on the condition being treated It is crucial to follow your doctors instructions and not to take more or less than prescribed as it can lead to serious side effects While taking Bortetor 2 Injection you may experience common side effects such as fatigue nausea vomiting and loss of appetite To prevent dehydration your doctor may advise you to drink plenty of fluids throughout the treatment Its important to note that this medication can cause tiredness and dizziness so it is advised not to drive or operate machinery Bortetor 2 Injection can reduce the number of blood cells including red and white blood cells which can increase the risk of infections Regular blood tests to monitor blood cell count as well as heart liver and blood uric acid levels are necessary during the course of treatment Before taking Bortetor 2 Injection consult with your doctor if you have any preexisting liver kidney heart disease or bleeding problems If you experience symptoms such as memory loss or cognitive difficulties it is important to seek medical advice Inform your healthcare team about all the medications you are currently using as Bortetor 2 Injection may interact with and be affected by other drugs It is not recommended to use this medication during pregnancy or while breastfeeding It is essential to use effective contraception for both males and females during the treatment to avoid pregnancy

Is Bortemap FDA approved?
Yes, Bortemap is approved by FDA

Is Bortirel a chemotherapy/hormonal drug/ cytotoxic?
Bortirel is not a hormone. It is a chemotherapy/ cytotoxic drug used in the treatment of cancers including multiple myeloma and mantle cell lymphoma

Does Tezomib cause constipation?
Tezomib may cause side effects such as constipation.

How does Bortiad work?
Bortiad belongs to the class of drugs called a proteasome inhibitor. It acts by blocking the action of proteasome, and affects the growth of cancerous (actively growing) cells